The report provides market dynamics and trends related to the global plasma fractionation market. In addition, it presents estimations and forecast of the market. It includes revenue generated from the sales of products such as albumin, immunoglobulins, and coagulation factor VIII. For the purpose of analysis, the global plasma fractionation market is segmented on the basis of product, sector, and region. The study estimates revenue generated from the sales of products such as albumin, immunoglobulins, coagulation factor VIII, and coagulation factor IX. By sector, the market is divided into public sector and private sector. This further provides an understanding of use of plasma fractionation products in the market. Moreover, the report covers revenue generated from sales of plasma fractionation products offered in region such as North America, Europe, Asia-Pacific, and LAMEA. Note: The volume market information for albumin & immunoglobulin is provided in metric tons. Similarly, coagulation factor VIII and factor IX is provided in million international units.

Medical devices used in the healthcare industries are increasingly connected to hospital network, internet, and other devices to provide features that increase the ability of healthcare organization to treat patients. This same features also increase the risk of various unauthorized access and cyber-attacks to critical data of the hospitals. Thus, healthcare organizations are using medical device security system to reduce the risk of cyber-attacks and to enhance the security of medical devices, which drives the growth of the market.

The antimicrobial coating industry is a billion-dollar sector and is growing rapidly. Antimicrobial coatings are applications of chemical agents applied on several surfaces to inhibit the growth of microbes. Microorganisms cannot be seen using the naked eye, and it becomes very difficult for an individual to know whether bad or good microbes contaminate a surface. Hence, antimicrobial coatings are used to inhibit the growth of microbial breeding on a surface. Antimicrobial coatings protect against microbes and protect surfaces from degradation as they cause no discoloration, leech, or affect the final look of the surface.

The report provides market dynamics and trends related to the global rapid acting insulin market. In addition, it presents the market estimations and forecast of the market. The study estimates revenue generated from the sales of different form of rapid insulin such as insulin lispro, insulin aspart, and insulin glulisine. The report covers revenue generated from rapid acting insulin for type 1 diabetes and type 2 diabetes. Moreover, the report excludes revenue generated from post-sale services of the rapid acting insulin market.

Structural health monitoring (SHM) refers to collection and analysis of data collected through a wide array of connected sensors during the service life of a structure or equipment. It is non-destructive and continuous method of identifying and quantifying the deterioration state of the object to predict the necessity of repair and maintenance.

The healthcare information technology sector has been experiencing strong growth in recent years. In specific, global digitization and new technological opportunities have played a major role to drive the growth of the sector. The healthcare IT sector involves a broad range of products and solutions that are widely contributing to more efficient and effective healthcare infrastructure. The industry trends that are fuelling the demand in the healthcare IT industry include artificial intelligence, telehealth services, individualized medical care, virtual reality, automation, and digitalization.

OVERVIEW The large molecules that constitute biopharmaceuticals differ from small molecules not only in their size but also in behavior, manufacture, and action in the human body. Manufacturing these molecules is significantly more complex than producing traditional pharmaceuticals. Despite the industry’s high complexity, however, outsourcing has become extremely popular. Not surprisingly, global contract manufacturing organizations (CMO) sales are growing steadily, fed not only by increased outsourcing but by overall growth in new and existing products, including clinical-trial supply. Contract manufacturing in the biopharmaceutical industry involves drug product manufacturing services on a fee-for-service basis for biopharmaceuticals, including formulation, fill, packaging and labeling, lyophilization, and other services related to the final production of the biopharmaceutical drug product. For biopharma companies requiring manufacturing capabilities and experience, partnering with a vaccine or biologics-focused contract manufacturing organization is likely to bring several advantages.